Format

Send to

Choose Destination
Hum Mol Genet. 2011 Dec 1;20(23):4644-54. doi: 10.1093/hmg/ddr398. Epub 2011 Sep 2.

Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex.

Author information

1
Telethon Institute of Genetics and Medicine, Via Pietro Castellino 111, Napoli 80131, Italy.

Abstract

Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with mutations in β-, γ- or δ-sarcoglycan (SG) genes. Patients with mutations in α-SG rarely have associated cardiomyopathy, or their cardiac pathology is very mild. We hypothesize that a fifth SG, ε-SG, may compensate for α-SG deficiency in the heart. To investigate the function of ε-SG in striated muscle, we generated an Sgce-null mouse and a Sgca-;Sgce-null mouse, which lacks both α- and ε-SGs. While Sgce-null mice showed a wild-type phenotype, with no signs of muscular dystrophy or heart disease, the Sgca-;Sgce-null mouse developed a progressive muscular dystrophy and a more anticipated and severe cardiomyopathy. It shows a complete loss of residual SGs and a strong reduction in both dystrophin and dystroglycan. Our data indicate that ε-SG is important in preventing cardiomyopathy in α-SG deficiency.

PMID:
21890494
PMCID:
PMC3209833
DOI:
10.1093/hmg/ddr398
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center